Epidemiology Practice Questions

Q: Which of the following best describes the structure of ICD-10?

Arranged in 3 volumes. The **International Classification of Diseases (ICD)** is a standard diagnostic tool for epidemiology, health management, and clinical purposes, maintained by the **World Health Organization (WHO)**. ### **Explanation of the Correct Answer** **Option C is correct.** The ICD-10 is structured into **three distinct volumes**, each serving a specific purpose: * **Volume 1 (Tabular List):** Contains the main classification (alphanumeric codes) arranged by body systems and etiology. * **Volume 2 (Instruction Manual):** Provides guidelines, rules, and instructions for recording and coding. * **Volume 3 (Alphabetical Index):** An index to the diseases and nature of injury, used to locate codes found in Volume 1. ### **Analysis of Incorrect Options** * **Option A:** ICD is not revised every 5 years. Historically, revisions occurred roughly every **10 years**. However, ICD-10 was used for nearly 30 years before ICD-11 was officially adopted in 2019 (implemented in 2022). * **Option B:** ICD-10 consists of **21 chapters** (not 10). These chapters use an alphanumeric coding scheme (A00 to Z99). * **Option D:** The ICD is produced and published by the **WHO**, not UNICEF. UNICEF focuses on child health and development, whereas WHO is the directing authority for international health work. ### **High-Yield NEET-PG Pearls** * **ICD-10 Structure:** It uses a **4-character alphanumeric code** (e.g., A15.0). The first character is a letter. * **ICD-11 Update:** The latest version (ICD-11) is fully digital, contains **26 chapters**, and uses a 4-character code with a letter in the second position. * **Dual Coding:** ICD-10 uses the **"Dagger and Asterisk"** system to code both the underlying generalized disease (dagger †) and its localized manifestation (asterisk *). * **Standardization:** The primary goal of ICD is to allow systematic recording, analysis, and comparison of mortality and morbidity data across different countries.

Q: Primary and secondary cases are used to define which epidemiological measure?

Serial interval. ### Explanation **Correct Answer: B. Serial interval** The **Serial Interval** is defined as the time interval between the onset of clinical symptoms in the **primary case** (the infector) and the onset of clinical symptoms in the **secondary case** (the infectee). It is a crucial measure in infectious disease epidemiology used to estimate the speed of spread of an epidemic. Because it relies on observable clinical symptoms, it is easier to measure in field settings than biological parameters. **Why other options are incorrect:** * **A. Generation time:** This refers to the time interval between the **receipt of infection** and the **maximal communicability** of the host. It focuses on the biological process of the pathogen rather than the clinical onset in primary/secondary cases. * **C. Secondary Attack Rate (SAR):** This is a measure of **infectivity** and spread within a closed group (like a household). It is calculated as the number of exposed persons developing the disease within the incubation period following exposure to a primary case, divided by the total number of susceptible contacts. It is a proportion/rate, not a time interval. **High-Yield Pearls for NEET-PG:** * **Incubation Period:** Time from entry of pathogen to the first appearance of signs/symptoms. * **Latent Period:** Time from infection to the onset of infectiousness (often shorter than the incubation period). * **Communicable Period:** The time during which an infectious agent may be transferred directly or indirectly from an infected person to another person. * If the **Serial Interval is shorter than the Incubation Period**, it indicates significant pre-symptomatic transmission (e.g., COVID-19).

Q: The life cycle of the malaria parasite in the mosquito is described as?

Cyclopropagative. ### Explanation In epidemiology, the relationship between a pathogen and its vector is classified based on whether the pathogen undergoes changes in form (development) or increases in number (multiplication) within the vector. **1. Why "Cyclopropagative" is Correct:** The malaria parasite (*Plasmodium*) undergoes **Cyclopropagative** transmission within the female *Anopheles* mosquito. * **Cyclo-:** Refers to a change in form (developmental cycle). The parasite transforms from gametocytes into ookinetes, oocysts, and finally sporozoites. * **Propagative:** Refers to multiplication. A single oocyst ruptures to release thousands of sporozoites, significantly increasing the parasite count. Since both development and multiplication occur, it is termed cyclopropagative. **2. Analysis of Incorrect Options:** * **Propagative (Option A):** The organism multiplies in number but does not change its form or undergo a developmental cycle. *Example: Plague bacilli in the rat flea.* * **Cyclodevelopmental (Option B):** The organism undergoes developmental changes (morphological stages) but does not multiply in number. *Example: Filarial parasite (Wuchereria bancrofti) in the Culex mosquito or Guinea worm in Cyclops.* **3. NEET-PG High-Yield Pearls:** * **Biological Transmission:** This includes all three types (Propagative, Cyclopropagative, Cyclodevelopmental). It is characterized by an **extrinsic incubation period** (the time required for the parasite to complete its cycle in the vector before it becomes infective). * **Mechanical Transmission:** The vector simply carries the pathogen on its body parts (e.g., Housefly carrying Typhoid or Cholera) without any biological interaction. * **Malaria Vector:** Only the female *Anopheles* mosquito is the vector because it requires a blood meal for egg production; the male mosquito feeds on plant juices.

Q: Which of the following statements is NOT true about tetanus?

Herd immunity is present for tetanus.. **Explanation** **Why Option B is the Correct Answer (The False Statement):** Herd immunity occurs when a significant portion of a population becomes immune to an infectious disease, thereby providing indirect protection to those who are not immune by reducing the chain of transmission. **Tetanus does not exhibit herd immunity** because it is not a communicable disease. The infection is acquired through environmental exposure (soil, dust, or manure containing *Clostridium tetani* spores) rather than person-to-person spread. Therefore, an immunized individual protects only themselves, not the community. **Analysis of Other Options:** * **Option A:** According to the National Immunization Schedule, if a person has been previously immunized, the protective antibody levels are generally considered to last for at least 5 years. In injury management, a booster is often not required if the last dose was within 5 years. * **Option C:** Tetanus **cannot be eradicated** because the causative agent, *C. tetani*, is a ubiquitous environmental saprophyte. We can eliminate the disease (clinical cases), but we cannot eliminate the spores from the soil. * **Option D:** **Neonatal Tetanus Elimination** is defined by the WHO as an incidence of **less than 1 case per 1,000 live births** in every district of a country. India achieved this milestone in 2015. **High-Yield Clinical Pearls for NEET-PG:** * **Incubation Period:** Typically 3–21 days (Average: 10 days). Shorter incubation periods correlate with a poorer prognosis. * **First Sign:** Trismus (Lockjaw) is the most common presenting symptom. * **Maternal and Neonatal Tetanus (MNT) Elimination:** India was declared MNT-free on July 14, 2015. * **Vaccine Type:** Tetanus toxoid is an **adsorbed toxoid**; it must never be frozen.

Q: A total of 5000 patients with glaucoma are identified and surveyed regarding family history of glaucoma. What is this study design called?

Case series report. ### Explanation **1. Why Case Series Report is Correct:** A **Case Series** is a descriptive study design that describes a group of individuals with a common characteristic (in this case, 5,000 patients with glaucoma). The study simply observes and describes the distribution of a variable (family history) within this specific group. * **Key Identifier:** There is **no comparison group** (no control group of people without glaucoma). Since the researcher is only looking at "cases" to identify patterns or generate hypotheses, it is a case series. **2. Why the Other Options are Incorrect:** * **B. Case-control study:** This requires two groups: Cases (with glaucoma) and Controls (without glaucoma). The study would then compare the frequency of family history between these two groups to calculate an Odds Ratio. * **C. Clinical trial:** This is an experimental study where an intervention (like a new drug) is applied to one group and compared against a placebo or standard treatment. * **D. Cohort study:** This starts with a group of exposed and unexposed individuals (e.g., those with and without family history) and follows them forward in time to see who develops glaucoma. It measures incidence and Relative Risk. **3. NEET-PG High-Yield Pearls:** * **Descriptive vs. Analytical:** Case reports and case series are *descriptive* (generate hypotheses). Case-control and cohort studies are *analytical* (test hypotheses). * **The "No Control" Rule:** If a question describes a large number of patients with a disease but mentions no comparison group, the answer is almost always a **Case Series**. * **Hierarchy of Evidence:** Case series are low on the evidence pyramid because they cannot prove a causal association due to the lack of a control group.

Q: Screening is useful for which of the following conditions?

All of the above. ### Explanation Screening is the process of identifying apparently healthy individuals who may have a disease, but do not yet have symptoms. For a screening program to be considered ethical and effective, it must fulfill the **Wilson and Jungner criteria**. **Why "All of the Above" is Correct:** The options provided represent the fundamental prerequisites for screening: * **Option A:** The disease must be an **important health problem** (high prevalence or high mortality/morbidity) to justify the cost and resources of a mass program. * **Option B:** There must be a recognizable **latent or early asymptomatic stage** (the "DPCP" or Lead Time) during which the disease can be detected. * **Option C:** This is the most critical ethical criterion. Screening is only useful if **early intervention** leads to a better prognosis than treatment at the symptomatic stage. If the outcome remains the same regardless of when treatment starts, screening is futile. **Analysis of Options:** Since all three criteria (importance of the disease, detectability in the latent phase, and benefit of early treatment) are essential components of a successful screening program, "All of the above" is the most comprehensive answer. **High-Yield NEET-PG Pearls:** * **Lead Time:** The period between early detection by screening and the time the disease would have been diagnosed clinically. * **DPCP (Detectable Pre-Symptomatic Check-up Period):** The interval between the first possible point of detection and the onset of symptoms. * **Iceberg Phenomenon:** Screening is primarily aimed at the "submerged portion" of the iceberg (latent, undiagnosed cases). * **Yield:** The amount of previously unknown disease detected in the population. * **Gold Standard:** The diagnostic test against which the screening test is compared (e.g., Biopsy for Cancer).

Question 1

Which of the following best describes the structure of ICD-10?

Accepted Answer

Arranged in 3 volumes

Answer

Revised every 5 years

Answer

Consists of 10 chapters

Answer

Was produced by UNICEF

Question 2

Primary and secondary cases are used to define which epidemiological measure?

Accepted Answer

Serial interval

Answer

Generation time

Answer

Secondary attack rate

Answer

None of the above

Question 3

Primordial prevention is done in which population group?

Accepted Answer

Population without risk factors

Answer

Population with risk factors

Answer

Whole population with low prevalence of disease

Answer

Population with the disease

Question 4

The age and sex structure of a population can be described by a?

Accepted Answer

Population pyramid

Answer

Life table

Answer

Correlation coefficient

Answer

Bar chart

Question 5

The life cycle of the malaria parasite in the mosquito is described as?

Accepted Answer

Cyclopropagative

Answer

Propagative

Answer

Cyclodevelopmental

Answer

None of the above

Question 6

In a study evaluating the health hazards of a drug versus a placebo, the following results were obtained: Placebo group: 15225 people, 1605 affected. Drug group: 15225 people, 1804 affected. Which of the following is true regarding the risk reduction?

Accepted Answer

RRR 11%, ARR 1%

Answer

Relative risk reduction (RRR) is 11%, Absolute risk reduction (ARR) is 11%

Answer

RRR 1%, ARR 11%

Answer

RRR 1%, ARR 1%

Question 7

Which of the following statements is NOT true about tetanus?

Accepted Answer

Herd immunity is present for tetanus.

Answer

Tetanus protection is maintained for 5 years if previously immunized.

Answer

Tetanus cannot be eradicated.

Answer

Elimination of tetanus is defined as less than 1 case per 1000 live births.

Question 8

A total of 5000 patients with glaucoma are identified and surveyed regarding family history of glaucoma. What is this study design called?

Accepted Answer

Case series report

Answer

Case-control study

Answer

Clinical trial

Answer

Cohort study

Question 9

Confounding factors can be eliminated by all except:

Accepted Answer

Ethical consideration

Answer

Matching

Answer

Randomization

Answer

Stratification

Question 10

Screening is useful for which of the following conditions?

Accepted Answer

All of the above

Answer

A disease which is an important health problem

Answer

A disease which can be diagnosed at a latent stage

Answer

A disease where early diagnosis and treatment favorably alters the natural history in a significant proportion of cases

Epidemiology — MCQs

Epidemiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?